Member Info for Thompi

“ To me it suggests an Ill informed telegram shorting exercise…” Which telegram group is that Ben?

Livedatasccount, they are valid questions you ask. An aggressive reply (DTW) and an attempt to shut the question down means that it is an uncomfortable question you have asked. At the very least we should have had some comms about the completion of C7.

Shame Starbright’s balanced and objective post has disappeared off the board.

I was waiting for NYsize to call one of us Derek, predictable if nothing else.

nysize, don’t be such a drama queen. i have not wet my knickers etc. it’s a share board for exchanging views. my view is the sp is ****e despite all the great progress. are you happy with 92p?

I’m holding but I’m not adding more until there is some clarity on funding.

The only one getting in a bit of a tizzy is you. Showing a bit of insecurity there…

What are you going to do NYsize? Bury your head in the sand and resort to abuse? You could always start a petition….

I take full responsibility for my investment decision. It doesn’t mean I am blind to the crap SP or the bizarre recent comms which seems to be mainly to individual investors. What is happening with C7, the fortnightly trial etc, how many patients have been dosed….?

NYsize you are close minded and lack any objectivity.

NYsize, does that mean you are happy with the SP nudging 52 week lows and the crappy comms?

The SP is now under the 95p discounted placing in October 2022, when C4 was in progress. The trial news has all been positive, but here we are sitting with an SP sub £1 and an almost daily grind down. Any LTH’s indifferent to that must be bonkers.

PL75,

“It's no different to any other time. They've nothing to update on. The same was true between Aug and Oct last year when the only operational update was the completion of the 6th cohort”.

I don’t agree, I think they DO have something to update on, which at the very least is the formal completion of C7. The current farcical comms means that we have learnt it has been “signed off” via feedback from PI’s who have been in contact touch with AS.. Ditto any news on the fortnightly study.

The have always previously RNS’d the completion of each cohort. They don’t have to release all the data. But I want to hear news direct from the company and not through third parties.

Thorn,

“As far as I'm concerned I don't think Avacta can comment at the moment.

I think a raise is in the offing so they can't say anything until it's in the open.

TW got to hear (as he unfortunately so often does) and put out a Short.

Time will tell.”

I am coming around to that view myself. The current SP decline has the hallmarks of a raise. I hope not, I have tried to average down (unsuccessfully) a lot recently.

Energyshares, well called out with Sheppy and his “small holding” which has miraculously morphed into 500k shares. I laughed so much I almost crashed the Ferrari when I was parking it in my 10 berth garage.

Watching2, why on earth would you describe GMCC’s post as being “disruptive”?

He adds a lot of research to the board and is clearly a very committed AVCT LTH.

Thanks BV for some very informative posts today.

Like others I find it frustrating that we have to find this information out from posters on this board, rather than directly from the company. I really hope they remedy this soon. In the meantime thank you to those who have shared the replies they have received from AS. It is greatly appreciated.

Thanks BV for taking the time to explain. Sorry for being a bit slow on the uptake.

“The planned Arm 2 dosing levels are 160, 200, 250 and 310. Their equivalents on a 3-weekly study (i.e. same amount after 6 weeks) are 240, 300, 375 and 465. C7 was at 385 with nio MTD, so all Arm 2 cohorts should be good for this simpler dosing regimen all the way.”

Sorry BV, I don’t understand the figures you used for the three weekly equivalents (240, 300, 375 and 465). I listened again to CC’s explanation and I’m still confused.

TG2D, you best contact Crescendo (prostate) & Artios (DDR assay breast/ovarian/prostate) and tell them to cancel their contracts.

Then you better contact all the KOL’s & researchers and advise them their research is invalid unless it is related to MBC.

Sorry RP.

And Tim, I’ve just watched your YouTube clip, it’s hard (“that what she said”) not to have a good laugh at it 😆 I’m going to drive myself and my better half nuts ( that what she said) saying it now.

Oh no, the pheasants are revolting!

Thanks Tim, so data being held back could be for two reasons. To protect the IP and to secure presentation slots at major conferences.